Kymera Therapeutics, Inc. (KYMR) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $39.21M | -16.7% |
| 2024 | $47.07M | -40.1% |
| 2023 | $78.59M | +67.8% |
| 2022 | $46.83M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $39.21M | -16.7% |
| 2024 | $47.07M | -40.1% |
| 2023 | $78.59M | +67.8% |
| 2022 | $46.83M | — |